Alexandria Venture Investments has contributed to the debut round for newly launched protein therapeutics startup Stablix Therapeutics.

WuXi AppTec co-led a round for Junshi and Yitai-backed Stemirna, which is putting the funding into development of an mRNA vaccine for covid-19.

Sham Innovation Santé is set to exit the oncology diagnostics test developer in an cash-and-stock acquisition expected to close later this year.

Stablix Therapeutics has launched with $63m in equity financing to commercialise research pioneered in Henry Colecraft’s laboratory at Columbia University.

Real estate platform developer raised $40m in a round led by Invesco Real Estate while Legend Capital contributed to a round for video shopping service Feiyu.Live.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Johnson & Johnson Innovation – JJDC has re-upped its commitment to the chronic conditions treatment provider having participated in a series C round valuing it at over $1bn post-money.

WuXi AppTec, Fosun, Sinopharm and Humanwell have all invested in the oncology treatment developer, which has filed to raise up to $100m.

SoftBank contributed to a $65m round for fresh produce marketplace Frubana while KDDI invested in food ordering service Menu at a $228m valuation.

The oncology therapy developer has filed for an IPO just two years after emerging from stealth to advance Harvard and Stanford research.